SCHEMBL845346

SCHEMBL845346

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)[C@@H]3CCCN3Cc3ccccc3)cc2)cc1)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1Cc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.53
NPSR1 Q6W5P4 2/20 0.51
KMT2A Q03164 1/20 0.49
KDM4E B2RXH2 1/20 0.48
LMNA P02545 1/20 0.48
HSD17B10 Q99714 1/20 0.48
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
KDM1A O60341 1/20 0.47
RCOR1 Q9UKL0 1/20 0.47
GAA P10253 1/20 0.47
PABPC1 P11940 1/20 0.46
FKBP1A P62942 1/20 0.46
MAPK1 P28482 1/20 0.46
HTT P42858 1/20 0.46
USP2 O75604 1/20 0.46
TSHR P16473 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13272391 1.00 ALDH1A1 (0.53) ALDH1A1NPSR1KMT2AKDM4ELMNA
SCHEMBL872299 0.91 ALDH1A1 (0.45) ALDH1A1NPSR1KMT2AKDM4ELMNA
SCHEMBL13272444 0.83 ALDH1A1 (0.56) ALDH1A1KDM4ELMNAHSD17B10CYP2C9
SCHEMBL1030175 0.83 ALDH1A1 (0.56) ALDH1A1KDM4ELMNAHSD17B10CYP2C9
SCHEMBL15116912 0.83 ALDH1A1 (0.56) ALDH1A1KDM4ELMNAHSD17B10CYP2C9
SCHEMBL845226 0.83 ALDH1A1 (0.56) ALDH1A1KDM4ELMNAHSD17B10CYP2C9
SCHEMBL845111 0.83 ALDH1A1 (0.56) ALDH1A1KDM4ELMNAHSD17B10CYP2C9
SCHEMBL845205 0.83 ALDH1A1 (0.56) ALDH1A1KDM4ELMNAHSD17B10CYP2C9
SCHEMBL845456 0.80 ALDH1A1 (0.52) ALDH1A1NPSR1KMT2AKDM4ELMNA
SCHEMBL844832 0.80 KDM4E (0.73) ALDH1A1NPSR1KMT2AKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed